KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) FCF Margin (2016 - 2025)

Astrana Health (ASTH) has disclosed FCF Margin for 16 consecutive years, with 0.63% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 140.0% to 0.63% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3.28% through Dec 2025, up 111.0% year-over-year, with the annual reading at 3.28% for FY2025, 111.0% up from the prior year.
  • FCF Margin hit 0.63% in Q4 2025 for Astrana Health, down from 0.77% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 21.07% in Q4 2022 to a low of 7.68% in Q4 2021.
  • Historically, FCF Margin has averaged 4.15% across 5 years, with a median of 3.04% in 2023.
  • Biggest YoY gain for FCF Margin was 2876bps in 2022; the steepest drop was -2394bps in 2022.
  • Year by year, FCF Margin stood at 7.68% in 2021, then skyrocketed by 374bps to 21.07% in 2022, then plummeted by -84bps to 3.47% in 2023, then tumbled by -158bps to 2.03% in 2024, then soared by 69bps to 0.63% in 2025.
  • Business Quant data shows FCF Margin for ASTH at 0.63% in Q4 2025, 0.77% in Q3 2025, and 13.67% in Q2 2025.